Here are three things to know:
1. Clutch has been in use since receiving FDA 510(k) clearance in 2017. This expanded commercial release offers the device’s proprietary spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening and migration.
2. The device’s bone opposing surfaces are enhanced with Ti-Bond technology in order to provide immediate stability and long-term fixation.
3. The device is part of Spinal Elements’ thoracolumbar portfolio.
More articles on MIS:
New case series highlights Wenzel Spine’s VariLift-LX for endoscopic TLIF: 4 things to know
5 things to know about Mazor Robotics’ Mazor X Surgical System
6 MIS spine device companies making the headlines
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
